Verve Therapeutics, Inc. - COMMON STOCK (VERV)

Historical Holders from Q2 2021 to Q1 2025

Symbol
VERV on Nasdaq
CUSIP
92539P101
Type / Class
Equity / COMMON STOCK
Shares outstanding
85.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
78.6M
Holdings value
$444M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
162
Number of buys
73
Number of sells
-77
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verve Therapeutics, Inc. - COMMON STOCK (VERV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $28.2M 6.18M BlackRock, Inc. Mar 31, 2025
MILLENNIUM MANAGEMENT LLC 4.6% $17.9M 3.92M Millennium Management LLC Dec 31, 2024
STATE STREET CORP 3.8% $14.8M 3.24M STATE STREET CORPORATION Dec 31, 2024

Institutional Holders of Verve Therapeutics, Inc. - COMMON STOCK (VERV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 292K $1.33M +$416K $4.57 15
2024 Q4 78.6M $444M +$18.8M $5.64 162
2024 Q3 75.2M $364M -$7.27M $4.84 169
2024 Q2 76.1M $371M +$9.87M $4.88 161
2024 Q1 4.39M $58.2M -$560K $13.28 17
2023 Q4 74.3M $1.04B +$151M $13.94 150
2023 Q3 63.8M $846M +$19.5M $13.26 127
2023 Q2 61.7M $1.16B -$20.1M $18.75 115
2023 Q1 63.3M $912M +$3.33M $14.42 122
2022 Q4 62.6M $1.21B +$9.15M $19.35 117
2022 Q3 60.4M $2.07B +$501M $34.35 119
2022 Q2 45.4M $693M -$28.2M $15.28 92
2022 Q1 46.6M $1.06B +$20M $22.82 91
2021 Q4 45.1M $1.66B +$125M $36.87 87
2021 Q3 38.7M $1.81B +$24.1M $47.00 72
2021 Q2 37.7M $2.25B +$2.25B $60.25 69